CAS 119717-21-4
:1H-Imidazole,4-[(1R)-1-(2,3-dimethylphenyl)ethyl]-
Description:
1H-Imidazole, 4-[(1R)-1-(2,3-dimethylphenyl)ethyl]- is a chemical compound characterized by its imidazole ring, which is a five-membered heterocyclic structure containing two nitrogen atoms. This compound features a chiral center, indicated by the (1R) configuration, which contributes to its potential biological activity and specificity in interactions. The presence of the 2,3-dimethylphenyl group enhances its lipophilicity and may influence its binding properties in biological systems. Imidazole derivatives are known for their diverse applications, including roles as pharmaceuticals, agrochemicals, and catalysts. The compound's structure suggests potential interactions with biological targets, making it of interest in medicinal chemistry. Additionally, the presence of the ethyl group may affect its solubility and reactivity. Overall, this compound exemplifies the complexity and versatility of imidazole derivatives in various chemical and biological contexts.
Formula:C13H16N2
Synonyms:- 1H-Imidazole,4-[1-(2,3-dimethylphenyl)ethyl]-, (R)-
- (-)-Medetomidine
- (R)-Medetomidine
- Levomedetomidine
- Mpv 1441
- l-Medetomidine
Sort by
The purity filter is not visible because current products do not have associated purity data for filtering.
Found 2 products.
Levomedetomidine-d4 L-Tartrate
CAS:Controlled Product<p>Applications Levomedetomidine-d4 L-Tartrate is a by-product in the synthesis of Dexmedetomidine-d4 L-Tartrate (d4-Major) (D299006). Dexmedetomidine-d4 L-Tartrate is the labeled salt analogue of Dexmedetomidine (D299000), an α2-Adrenergic agonist; (+)-isomer of Medetomidine; sedative; analgesic.<br>References Rajala, R., et al.: Eur. J. Pharm. Sci., 1, 219 (1994); Jalonen, J., et al.: Anesthesiology, 86, 331 (1997); Talke, P., et al.: Anesth. Analg., 85, 1136 (1997); Bhana, N., et al.: Drugs, 59, 263 (2000)<br></p>Formula:C13H12D4N2·C4H6O6Color and Shape:NeatMolecular weight:354.39

